PMC:7319919 / 5554-5766 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T31","span":{"begin":22,"end":30},"obj":"Disease"},{"id":"T32","span":{"begin":106,"end":139},"obj":"Disease"}],"attributes":[{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"entral role in severe COVID-19 [3,8].\nIn addition, imatinib has shown in vitro antiviral activity against severe acute respiratory syndrome and Middle East respiratory syndrome coronaviruses [9], which are phylog"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T60","span":{"begin":60,"end":63},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T61","span":{"begin":89,"end":97},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"entral role in severe COVID-19 [3,8].\nIn addition, imatinib has shown in vitro antiviral activity against severe acute respiratory syndrome and Middle East respiratory syndrome coronaviruses [9], which are phylog"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T45","span":{"begin":51,"end":59},"obj":"Chemical"},{"id":"T46","span":{"begin":79,"end":88},"obj":"Chemical"}],"attributes":[{"id":"A45","pred":"chebi_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/CHEBI_45783"},{"id":"A46","pred":"chebi_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":"entral role in severe COVID-19 [3,8].\nIn addition, imatinib has shown in vitro antiviral activity against severe acute respiratory syndrome and Middle East respiratory syndrome coronaviruses [9], which are phylog"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"139","span":{"begin":22,"end":30},"obj":"Disease"},{"id":"147","span":{"begin":177,"end":190},"obj":"Species"},{"id":"150","span":{"begin":51,"end":59},"obj":"Chemical"}],"attributes":[{"id":"A139","pred":"tao:has_database_id","subj":"139","obj":"MESH:C000657245"},{"id":"A147","pred":"tao:has_database_id","subj":"147","obj":"Tax:11118"},{"id":"A150","pred":"tao:has_database_id","subj":"150","obj":"MESH:D000068877"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"entral role in severe COVID-19 [3,8].\nIn addition, imatinib has shown in vitro antiviral activity against severe acute respiratory syndrome and Middle East respiratory syndrome coronaviruses [9], which are phylog"}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T75","span":{"begin":22,"end":30},"obj":"SP_7"},{"id":"T76","span":{"begin":51,"end":59},"obj":"CHEBI:14434;CHEBI:14434"},{"id":"T77","span":{"begin":119,"end":130},"obj":"UBERON:0001004"},{"id":"T78","span":{"begin":156,"end":167},"obj":"UBERON:0001004"},{"id":"T79","span":{"begin":177,"end":190},"obj":"NCBITaxon:11118"},{"id":"T32706","span":{"begin":22,"end":30},"obj":"SP_7"},{"id":"T45081","span":{"begin":51,"end":59},"obj":"CHEBI:14434;CHEBI:14434"},{"id":"T88775","span":{"begin":119,"end":130},"obj":"UBERON:0001004"},{"id":"T61507","span":{"begin":156,"end":167},"obj":"UBERON:0001004"},{"id":"T25185","span":{"begin":177,"end":190},"obj":"NCBITaxon:11118"}],"text":"entral role in severe COVID-19 [3,8].\nIn addition, imatinib has shown in vitro antiviral activity against severe acute respiratory syndrome and Middle East respiratory syndrome coronaviruses [9], which are phylog"}